Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
strong sense of responsibility; and be capable of managing various aspects of a project and meeting deadlines. The appointee will assist the Principal Investigator in implementing a teaching development
-
able to work independently as well as in a team. Prior experience in vaccine/drug development and/or clinical trials is advantageous. The appointee will be responsible for the collaborative projects
-
(R3) Country Hong Kong Application Deadline 1 May 2025 - 00:00 (UTC) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
independently. The appointee will mainly work for the Programme for International Student Assessment (PISA) 2025 in Hong Kong. He/She will provide assistance to the National Project Manager in coordinating and
-
Researcher (R3) Country Hong Kong Application Deadline 31 Mar 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
programs, oversee data collection and analysis, prepare reports and presentations, supervise research assistants, and perform other relevant tasks as assigned. There will be many opportunities to collaborate
-
, aerosol simulation data, airflow data, as well as the development of an analysis pipeline. Enquiries about the duties of the post should be sent to Dr. Eric Schuldenfrei at eschulde@hku.hk . A highly
-
experience in one or more of the following areas: development of methods for multi-omics data integration, application of machine learning models in life science, single cell data analysis and spatial
-
project partners and collaborators, and performing other duties as assigned. Publication opportunities and professional development support are available. Shortlisted candidates will be invited to attend a
-
as well as in a team. The appointee will work on interdisciplinary projects related to the development of novel therapeutic agents targeting cancer-related proteins for therapy. These are collaborative